MAKE SURE YOUR DENTIST IS AN ADA MEMBER!: ADA Members Adhere to Strict Code of Ethics and Conduct. You should make sure you are SEEING AN ADA MEMBER DENTIST! Visit ADA Find-A-Dentist to Find One Near YOU

Ninth District Headquarters Office - Hawthorne, NY

2025 Ninth District President

Dr. Renuka Bijoor

ADA Update: a new login experience

We’re updating how you log in to your NYSDA and ADA account.

Learn more

RENEW YOUR MEMBERSHIP TODAY!

3 EASY WAYS TO PAY 1 ONLINE: nysdental.org/renew 2 MAIL: Return dues stub and payment 3 PHONE: 1-800-255-2100

RENEW TODAY!

Member Assistance Program (MAP)

Life comes with challenges, but your new Member Assistance Program (MAP) is here to help. This free, confidential benefit is available to you and your household, offering resources and services to support mental health, reduce stress, and make life easier.

LEARN MORE

Welcome to the Ninth District Dental Association

The Ninth District Dental Society was formed in 1909 and renamed to the Ninth District Dental Association in 2002. We have a membership of over 1500 dentists in 5 counties: Westchester, Rockland, Dutchess, Orange and Putnam.

In its quest to serve both the public and the profession, the Ninth District embodies the highest ideals.

The mission of the 9^th District Dental Association is to serve and support its members and the public by improving the oral health of our community through Advocacy, Continuing Education and Camaraderie.

The Ninth District Dental Association, in Partnership with the New York State Dental Foundation (NYSDF), will be hosting an

Oral Health Screening Event
with the Hudson Valley Renegades and
Sponsored by Henry Schein Cares Foundation

September 5, 2025
6:00 pm - 9:00 pm

*** * * * * * * * * ***

Don't Miss the 9th District Dental Association's General Meeting
Wednesday, September 17, 2025

The Westchester Manor
140 Saw Mill River Road
Hastings-on-Hudson, NY

Register

Mahnaz Fatahzadeh, D.M.D., M.S.D.
Completed her Oral Medicine fellowship and MSD degree at the Rutgers School of Dental Medicine where she holds a faculty appointment as a professor of Oral Medicine and as an attending at the University hospital. Dr. Fatahzadeh is a diplomat of American Board of Oral Medicine and director of pre and post-doctoral oral medicine training and Oral Mucosal Diseases Clinic at the Rutgers School of Dental Medicine.

"Orofacial Manifestations of Systemic Diseases"

Course Objectives

Oral cavity is readily accessible for inspection and a gateway for assessment of general health. In fact, many systemic conditions affecting organs far from the head and neck region could manifest in the orofacial region, sometimes prior to their diagnosis. Abnormalities detected in the orofacial region may also represent complications related to medical therapy or raise concerns about substance abuse. This program provides illustrative examples of orofacial findings associated with diagnosed or subjectively silent systemic disease, medical therapy and substance abuse. Relevant signs, symptoms, and diagnostics are reviewed and the potential role of oral health care providers in recognition, referral, follow-up and overall management is emphasized.

Meeting Exhibitors (so far): (company names are links to their websites)

After Hours Cleaning

Altfest Personal Wealth Management

BonaDent Dental Labs

DDSMatch

Epstein Practice Brokerage

Garfield Refining Company

General Refining

Komet

M&T Bank

MLMIC Insurance Company

Orion Dental Solutions

Singular Anesthesia Services

Latest News Around the Tripartite

FDA Holding Digital Health Advisory Committee Meeting

Sep 12, 2025

Per the notice below, the United States Food and Drug Administration (FDA) is holding a virtual meeting of its Digital Health Advisory Committee that will be Webcast for free.

FDA Announces Digital Health Advisory Committee Meeting

The U.S. Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Digital Health Advisory Committee. The Committee advises the Commissioner of Food and Drugs on issues related to digital health technologies, providing relevant expertise and perspective to improve the FDA's understanding of the benefits, risks, and clinical outcomes associated with the use of these technologies. On November 6, 2025, the FDA plans to hold the Digital Health Advisory Committee meeting virtually from 9:00 a.m. to 6:00 p.m. ET. The Committee will discuss and make recommendations on the topic of generative artificial intelligence-enabled digital mental health medical devices. Many of these medical devices pose novel risks. As mental health devices continue to evolve in complexity, regulatory approaches ideally will also evolve to accommodate these novel challenges and opportunities to provide a reasonable assurance of their safety and effectiveness while promoting innovation to support public health. The Committee will discuss the benefits, risks to health, and risk mitigations that might be considered for these new digital mental health devices, including premarket evidence and postmarket monitoring considerations. The meeting will be open to the public. The FDA is establishing a docket for public comment. Registration is not required to attend the meeting.

Read More

Important Participation Due Dates:

Interested persons may present data, information, or views, orally or in writing, on issues pending before the Committee.

October 9, 2025: E-mail Letise.Williams@fda.hhs.gov to request to make oral presentations during the public comment session of the meeting.
October 17, 2025: Submit written comments on the public docket (FDA-2025-N-2338) to be reviewed by the Committee prior to the meeting.
October 30, 2025: Request special accommodations for the meeting.
December 8, 2025: Submit written comments to the docket for review and consideration by the FDA.